Panome Bio uses the SomaScan 7K Assay to help you advance your research in biomarker discovery and drug development with a multi-omic approach.
The SomaScan® 7K assay is a platform that screens 7,000 unique proteins from biological samples. Coupling metabolomics and proteomics will provide correlations and insights between the metabolome and proteome, giving you a full picture of pathways and getting you results closer to phenotype.
Somascan 7k Proteomics Assay is suitable for a wide range of applications and has been used to investigate diverse biological systems, such as cancer, neurodegenerative diseases, infectious diseases, and more.
With our assay, you can uncover novel biomarkers, elucidate signaling pathways, and gain insights into the underlying mechanisms of diseases.